| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/25/2005 | EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/25/2005 | EP1532161A2 Vectors for expression of hml-2 polypeptides |
| 05/25/2005 | EP1531842A2 Regulation of cell growth by muc1 |
| 05/25/2005 | EP1531676A2 Compositions and methods for liver growth and liver protection |
| 05/25/2005 | EP1307594A4 Association of sim2 with cancer |
| 05/25/2005 | EP1279039A4 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 05/25/2005 | EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
| 05/25/2005 | EP1056473B1 Targeted delivery of biologically active media |
| 05/25/2005 | EP1017421B1 Use of adenoviral vectors expressing VEGF or PDGF FOR HEALING TISSUE DEFECTS AND INDUCING HYPERVASCULARITY IN MAMMALIAN TISSUE |
| 05/25/2005 | EP0907370B1 Hla-a2.1 binding peptides and their uses |
| 05/25/2005 | EP0813419B1 Modulators of regulatory proteins |
| 05/25/2005 | EP0479866B2 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus |
| 05/25/2005 | CN1620655A System and method for controlling user interface attribute by data |
| 05/25/2005 | CN1620508A Transgenic organism |
| 05/25/2005 | CN1620500A Corona-virus-like particles comprising functionally deleted genomes |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 05/25/2005 | CN1618978A Configuration of cell facter IL-24 eucargon expression carrier and application |
| 05/25/2005 | CN1618969A Mammalian sytokine-like polypeptide-10 |
| 05/25/2005 | CN1618468A Series non-virus carrier, and medicinal composition contg. same |
| 05/25/2005 | CN1618459A Translation initiation factor eIF-5A and medical application of it and syntenin complex |
| 05/25/2005 | CN1203183C Retroviral vectors comprising functional splice donor site and a functional splice acceptor site |
| 05/25/2005 | CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis |
| 05/25/2005 | CN1203179C DNA sequence and recombination production method of graminae allergen |
| 05/25/2005 | CN1203091C TGF (b) 1 inhibitor peptides |
| 05/25/2005 | CA2448831A1 Multi-stage cascade boosting vaccine |
| 05/24/2005 | US6897293 A DNA sequence encoding a gax protein or portion, which inhibits vascular smooth muscle cell proliferation, useful in the treatment of blood vessel diseases |
| 05/24/2005 | US6897200 Drug delivery a macromolecular complexes containing antitumor agent conjugated with a viral and non-viral RNA or vectors; stable, nonhydrolysis, gene therapy |
| 05/24/2005 | US6897197 Method of inhibiting cell proliferation using an anti-oncogene protein |
| 05/24/2005 | US6897069 System and method for electroporating a sample |
| 05/24/2005 | US6897068 Polynucleotide complex delivery |
| 05/24/2005 | US6897066 For diagnosis/therapy of human genetic disorders; in situ genetic engineering/cloning |
| 05/24/2005 | US6897063 Accessory functions for use in recombinant AAV virion production |
| 05/24/2005 | US6897060 Composition comprising multipotent neural stem cells for generation of hematopoietic cells |
| 05/24/2005 | US6897057 Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression |
| 05/24/2005 | US6897056 32544, a novel human phospholipase C and uses thereof |
| 05/24/2005 | US6897054 For controlling in vitro cell proliferation; genetic engineering |
| 05/24/2005 | US6897052 N-acetylglycosaminyl transferase genes |
| 05/24/2005 | US6897045 Adeno-associated virus vectors |
| 05/24/2005 | US6897041 For treating/preventing staphylococcal infections; transcription regulators; ion exchange resins; bacteriophages; genetic engineering/cloning |
| 05/24/2005 | US6897039 For treatment of cardiovascular diseases. |
| 05/24/2005 | US6897018 DLC-1 gene deleted in cancers |
| 05/24/2005 | US6896904 Multilayer crosslinking porous structure; prosthetic bones, drug delivery |
| 05/20/2005 | CA2450297A1 Method for preventing mineralization in the periodontal ligament (pdl) |
| 05/19/2005 | WO2005045428A2 Methods and compositions for modulating apoptosis |
| 05/19/2005 | WO2005045043A1 C/ebpalpha gene targeting constructs and uses thereof |
| 05/19/2005 | WO2005045036A2 Rna interference mediated inhibition of hairless (hr) gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | WO2005045025A2 Cloning and characterization of 5’ flanking regions of a human aggrecanase-1 gene |
| 05/19/2005 | WO2005044993A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 05/19/2005 | WO2005044987A2 Tocopherol associated protein and uses thereof |
| 05/19/2005 | WO2005044282A1 Use of nucleic acids comprising an exocyclic adduct |
| 05/19/2005 | WO2005032511A3 Nanoparticulate therapeutic biologically active agents |
| 05/19/2005 | WO2005027848A3 Methods for screening osteogenic compounds targeting syk kinase and/or vav3 and uses of syk modulators and/or vav modulators |
| 05/19/2005 | WO2005006958A3 Modulation of ceacam1 expression |
| 05/19/2005 | WO2004098526A3 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
| 05/19/2005 | WO2004076639B1 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus |
| 05/19/2005 | WO2004064776A3 Methods of preparation of live attenuated bacterial vaccines by alteration of dna adenine methylase (dam) activity in those bacteria |
| 05/19/2005 | WO2004060912A3 Chimeric capsid proteins and expression vectors for monocistronic expression of multiple genes |
| 05/19/2005 | WO2004044141A3 Conjugated oligomeric compounds and their use in gene modulation |
| 05/19/2005 | WO2004041924A3 Non-phosphorous-linked oligomeric compounds and their use in gene modulation |
| 05/19/2005 | WO2004016764A3 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 05/19/2005 | WO2004016726A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 05/19/2005 | WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 05/19/2005 | US20050108784 Expression vector comprising nucleotide sequences coding spinocerebellar ataxia-1 gene for use in treatment and prevention of nervous system disorders |
| 05/19/2005 | US20050108782 Transgenic RS1-/- animal and uses thereof |
| 05/19/2005 | US20050108781 Expression vector comprising nucleotide sequences coding heterologous polypeptides for use as gene transfer and expression tool; bioreactors |
| 05/19/2005 | US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases |
| 05/19/2005 | US20050107344 Bi phosphate containing protonated compound with two end groups; disinfecting surfaces of surgical equipments and skin |
| 05/19/2005 | US20050107327 Administration of an NPY receptor antagonist to decrease the expression of the NPY gene; control cholesterol, LDL cholesterol and triglyserides in blood, prevent development of atherosclerosis |
| 05/19/2005 | US20050107326 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 05/19/2005 | US20050107325 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs |
| 05/19/2005 | US20050107324 Nucleotide sequences for inhibiting the expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule, coronavirus receptor; prevent coronavirus infections, SARS (Severe Acute Respiratory Syndrome); viricide biodrugs |
| 05/19/2005 | US20050107323 Cardiac arrhythmia treatment methods |
| 05/19/2005 | US20050107322 Compositions for inducing immune responses |
| 05/19/2005 | US20050107320 Improve phenotypic response and receptive to the therapeutic agent by administering a vector comprising a gene into a mammalian cell, wherein expression of the heterologous protein within the cell; brian neurological disorder, Parkinson's disease; tissue-targeted therapy |
| 05/19/2005 | US20050107318 Methods of treating diabetes and other blood sugar disorders |
| 05/19/2005 | US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease |
| 05/19/2005 | US20050107316 Enzyme inhibitor of polo like kinase, duplex RNAs antisense oligonucleotides, short interfering RNA as anticarcinogenic agent biodrug |
| 05/19/2005 | US20050107314 Modulation of cd200 receptors |
| 05/19/2005 | US20050107256 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 05/19/2005 | US20050106732 Pseudotyped with nucleotide sequence encoding envelope protein; transducing or infecting adipose tissue cells; metabolic disorders |
| 05/19/2005 | US20050106731 siRNA-mediated gene silencing with viral vectors |
| 05/19/2005 | US20050106729 Gene transfer methods and compositions |
| 05/19/2005 | US20050106724 Self renewing dental follicle tissues for use in generating periodontal ligament like membrane structures; tissue repair and regenerative medicine |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106654 Animal model lacking histone deacetylase (HDAC) for use as diagnostic tool in detection, diagnosis and prevention of cardiac hypertrophy |
| 05/19/2005 | US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents |
| 05/19/2005 | US20050106620 Novel ovarian tumor antigen (OVR107) for use in diagnosis, prognosis, classification and imaging of cell proliferative disorders |
| 05/19/2005 | US20050106616 DLC-1 gene deleted in cancers |
| 05/19/2005 | US20050106599 Nucleotide sequences coding secretfed protein for use as tools in generating antibodies for use in forensics, gene therapeutics and diagnostics and chromosome mapping |
| 05/19/2005 | US20050106584 Alu-derived exons and uses thereof for detection and treatment of genetic diseases |
| 05/19/2005 | US20050106565 Hybrid nucleic acids, ant antibodies thereof; insecticide |
| 05/19/2005 | US20050106559 Viral vector |
| 05/19/2005 | US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders |
| 05/19/2005 | US20050106162 Immunisation against chlamydia trachomatis |
| 05/19/2005 | US20050106154 GASP1: a follistatin domain containing protein |
| 05/19/2005 | US20050106152 Using protein antagonist; amino acid sequence; antisense nucleotide; inducing apoptosis |
| 05/19/2005 | US20050106143 Collapsin response mediator protein; measurement of gene expression |
| 05/19/2005 | US20050106130 Transgenic human cells expressing antiproliferative agents; gene therapy; anticancer agents; tissue engineering; generating immunology response |
| 05/19/2005 | US20050106128 Novel methods of treatment and deliver modes |